Keywords
Last Name
Institution

Thomas Kieber-Emmons

TitleProfessor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentPathology, College of Medicine
DivisionPathology Academic
Address309-2 Biomedical Research II
200 South Cedar
Mail Slot # 824
Little Rock AR 72202
Phone501-526-5930
vCardDownload vCard
    Other Positions
    TitleAssistant Professor
    InstitutionUniversity of Arkansas for Medical Sciences
    DepartmentBiostatistics, College of Medicine
    DivisionBiostastistics Admin


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Hutchins LF, Makhoul I, Emanuel PD, Pennisi A, Siegel ER, Jousheghany F, Guo X, Pashov AD, Monzavi-Karbassi B, Kieber-Emmons T. Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects. Oncotarget. 2017 Nov 17; 8(58):99161-99178. PMID: 29228761.
      View in: PubMed
    2. Kieber-Emmons T, Monzavi-Karbassi B, Hutchins LF, Pennisi A, Makhoul I. Harnessing benefit from targeting tumor associated carbohydrate antigens. Hum Vaccin Immunother. 2017 02; 13(2):323-331. PMID: 27929800.
      View in: PubMed
    3. Kieber-Emmons T, Makhoul I, Pennisi A, Siegel ER, Emanuel PD, Monzavi-Karbassi B, Steplewski Z, Beck JT, Hutchins LF. Managing Expectations in the Transition to Proof of Concept Studies. Rev Recent Clin Trials. 2017; 12(2):111-123. PMID: 28325150.
      View in: PubMed
    4. Monzavi-Karbassi B, Jousheghany F, Kieber-Emmons T. Tumor-associated Glycans and Tregs in Immunogenicity of an Autologous Cell-based Vaccine. Immunol Invest. 2016 Oct 19; 1-13. PMID: 27759476.
      View in: PubMed
    5. Pennisi A, Kieber-Emmons T, Makhoul I, Hutchins L. Relevance of Pathological Complete Response after Neoadjuvant Therapy for Breast Cancer. Breast Cancer (Auckl). 2016; 10:103-6. PMID: 27478380; PMCID: PMC4961053.
    6. Monzavi-Karbassi B, Siegel ER, Medarametla S, Makhoul I, Kieber-Emmons T. Breast cancer survival disparity between African American and Caucasian women in Arkansas: A race-by-grade analysis. Oncol Lett. 2016 Aug; 12(2):1337-1342. PMID: 27446434.
      View in: PubMed
    7. Monzavi-Karbassi B, Gentry R, Kaur V, Siegel ER, Jousheghany F, Medarametla S, Fuhrman BJ, Safar AM, Hutchins LF, Kieber-Emmons T. Pre-diagnosis blood glucose and prognosis in women with breast cancer. Cancer Metab. 2016; 4:7. PMID: 27054036; PMCID: PMC4822279.
    8. Saha S, Murali R, Pashov A, Kieber-Emmons T. The Potential Role of Solvation in Antibody Recognition of the Lewis Y Antigen. Monoclon Antib Immunodiagn Immunother. 2015 Oct; 34(5):295-302. PMID: 26492616; PMCID: PMC4625738 [Available on 10/01/16].
    9. Steplewski Z, Thurin M, Kieber-Emmons T. Antibodies: At The Nexus of Antigens and Cancer Vaccines. J Infect Dis. 2015 Jul 15; 212 Suppl 1:S59-66. PMID: 26116735; PMCID: PMC4490205.
    10. Garimalla S, Kieber-Emmons T, Pashov AD. The Patterns of Coevolution in Clade B HIV Envelope's N-Glycosylation Sites. PLoS One. 2015; 10(6):e0128664. PMID: 26110648; PMCID: PMC4482261.
    11. Yao-Borengasser A, Monzavi-Karbassi B, Hedges RA, Rogers LJ, Kadlubar SA, Kieber-Emmons T. Adipocyte hypoxia promotes epithelial-mesenchymal transition-related gene expression and estrogen receptor-negative phenotype in breast cancer cells. Oncol Rep. 2015 Jun; 33(6):2689-94. PMID: 25823469; PMCID: PMC4431437.
    12. Herman D, Leakey TI, Behrens A, Yao-Borengasser A, Cooney CA, Jousheghany F, Phanavanh B, Siegel ER, Safar AM, Korourian S, Kieber-Emmons T, Monzavi-Karbassi B. CHST11 gene expression and DNA methylation in breast cancer. Int J Oncol. 2015 Mar; 46(3):1243-51. PMID: 25586191; PMCID: PMC4324579.
    13. Kieber-Emmons T, Pennisi A, Lane A, Siegel E, Cannon M, Monzavi-Karbassi B, Makhoul I. Defining and managing expectations for early immunotherapy cancer trials. Rev Recent Clin Trials. 2015; 10(1):47-60. PMID: 25723736.
      View in: PubMed
    14. Makhoul I, Hutchins L, Emanuel PD, Pennisi A, Siegel E, Jousheghany F, Monzavi-Karbassi B, Kieber-Emmons T. Moving a Carbohydrate Mimetic Peptide into the clinic. Hum Vaccin Immunother. 2015; 11(1):37-44. PMID: 25483513; PMCID: PMC4514369.
    15. Saha S, Pashov A, Siegel ER, Murali R, Kieber-Emmons T. Defining the recognition elements of Lewis Y-reactive antibodies. PLoS One. 2014; 9(8):e104208. PMID: 25117628; PMCID: PMC4130537.
    16. Kieber-Emmons T, Saha S, Pashov A, Monzavi-Karbassi B, Murali R. Carbohydrate-mimetic peptides for pan anti-tumor responses. Front Immunol. 2014; 5:308. PMID: 25071769; PMCID: PMC4075079.
    17. Murali R, Kieber-Emmons T. Cancer immunotherapeutics: evolution of monoclonal antibodies to peptide immunogens. Monoclon Antib Immunodiagn Immunother. 2014 Jun; 33(3):179-82. PMID: 24892996.
      View in: PubMed
    18. Steplewski Z, Kieber-Emmons T. Hilary Koprowski, MD December 5, 1916-April 11, 2013. Monoclon Antib Immunodiagn Immunother. 2014 Jun; 33(3):153. PMID: 24937248.
      View in: PubMed
    19. Steplewski Z, Kieber-Emmons T. Hilary Koprowski, MD: A lifetime of work. Monoclon Antib Immunodiagn Immunother. 2014 Jun; 33(3):1-43. PMID: 24937247.
      View in: PubMed
    20. Hudson CL, Topaloglu U, Bian J, Hogan W, Kieber-Emmons T. Automated Tools for Clinical Research Data Quality Control using NCI Common Data Elements. AMIA Jt Summits Transl Sci Proc. 2014; 2014:60-9. PMID: 25717402; PMCID: PMC4333694.
    21. Monzavi-Karbassi B, Pashov A, Kieber-Emmons T. Tumor-Associated Glycans and Immune Surveillance. Vaccines (Basel). 2013 Jun 17; 1(2):174-203. PMID: 26343966; PMCID: PMC4515579.
    22. Ohtaki A, Kieber-Emmons T, Murali R. Structure-based peptide mimicry of tumor-associated antigens. Monoclon Antib Immunodiagn Immunother. 2013 Feb; 32(1):1-5. PMID: 23600498.
      View in: PubMed
    23. Kieber-Emmons T, Monzavi-Karbassi B, Pashov A, Saha S, Murali R, Kohler H. The promise of the anti-idiotype concept. Front Oncol. 2012; 2:196. PMID: 23267437; PMCID: PMC3526099.
    24. Saha S, Karbassi B, Otaki A, Murali R, Kieber-Emmons T. Anticarbohydrate Antibodies - from molecular basis to clinical applications. Carbohydrate Mimetic Peptide Vaccines. 2012.
    25. Hennings L, Artaud C, Jousheghany F, Monzavi-Karbassi B, Pashov A, Kieber-Emmons T. Carbohydrate mimetic peptides augment carbohydrate-reactive immune responses in the absence of immune pathology. Cancers (Basel). 2011 Nov 11; 3(4):4151-69. PMID: 24213131; PMCID: PMC3763416.
    26. Cooney CA, Jousheghany F, Yao-Borengasser A, Phanavanh B, Gomes T, Kieber-Emmons AM, Siegel ER, Suva LJ, Ferrone S, Kieber-Emmons T, Monzavi-Karbassi B. Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells. Breast Cancer Res. 2011 Jun 09; 13(3):R58. PMID: 21658254; PMCID: PMC3218947.
    27. Yeary KH, Mason M, Turner J, Kieber-Emmons T, Chow M, Hine RJ, Henry-Tillman R, Greene P. A community-based approach to translational research addressing breast cancer disparities. Transl Behav Med. 2011 Jun; 1(2):224-33. PMID: 24073047; PMCID: PMC3717653.
    28. Pashov A, Monzavi-Karbassi B, Kieber-Emmons T. Glycan mediated immune responses to tumor cells. Hum Vaccin. 2011 Jan-Feb; 7 Suppl:156-65. PMID: 21321481.
      View in: PubMed
    29. Hennings L, Jousheghany F, Pashov A, Artaud C, Monzavi-Karbassi B, Kieber-Emmons T. Carbohydrate mimetic peptides induce tumor-associated carbohydrate-reactive antibodies in the absence of pathological autoimmunity. Cancers. 2011; (3):4151-4169.
    30. Monzavi-Karbassi B, Hine RJ, Stanley JS, Ramani VP, Carcel-Trullols J, Whitehead TL, Kelly T, Siegel ER, Artaud C, Shaaf S, Saha R, Jousheghany F, Henry-Tillman R, Kieber-Emmons T. Fructose as a carbon source induces an aggressive phenotype in MDA-MB-468 breast tumor cells. Int J Oncol. 2010 Sep; 37(3):615-22. PMID: 20664930; PMCID: PMC3267577.
    31. Pashov A, Monzavi-Karbassi B, Raghava GP, Kieber-Emmons T. Bridging innate and adaptive antitumor immunity targeting glycans. J Biomed Biotechnol. 2010; 2010:354068. PMID: 20617150; PMCID: PMC2896669.
    32. Todorova VK, Klimberg VS, Hennings L, Kieber-Emmons T, Pashov A. Immunomodulatory effects of radiofrequency ablation in a breast cancer model. Immunol Invest. 2010; 39(1):74-92. PMID: 20064086.
      View in: PubMed
    33. Pashov A, Garimalla S, Monzavi-Karbassi B, Kieber-Emmons T. Carbohydrate targets in HIV vaccine research: lessons from failures. Immunotherapy. 2009 Sep; 1(5):777-94. PMID: 20636023.
      View in: PubMed
    34. Pashov A, Monzzavi-Karbassi, B, Kieber-Emmons T. Immune-surveillance and immunotherapy lessons from carbohydrate mimotypes. 2009.
    35. Pashov A, Monzavi-Karbassi B, Kieber-Emmons T. Immune surveillance and immunotherapy: lessons from carbohydrate mimotopes. Vaccine. 2009 May 26; 27(25-26):3405-15. PMID: 19200843.
      View in: PubMed
    36. Wondimu A, Zhang T, Kieber-Emmons T, Gimotty P, Sproesser K, Somasundaram R, Ferrone S, Tsao CY, Herlyn D. Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice. Cancer Immunol Immunother. 2008 Jul; 57(7):1079-89. PMID: 18157673; PMCID: PMC3426288.
    37. Korourian S, Siegel E, Kieber-Emmons T, Monzavi-Karbassi B. Expression analysis of carbohydrate antigens in ductal carcinoma in situ of the breast by lectin histochemistry. BMC Cancer. 2008 May 14; 8:136. PMID: 18479514; PMCID: PMC2394536.
    38. Whitehead TL, Holley AW, Korourian S, Shaaf S, Kieber-Emmons T, Hakkak R. (1)H nuclear magnetic resonance metabolomic analysis of mammary tumors from lean and obese Zucker rats exposed to 7,12-dimethylbenz[a]anthracene. Int J Mol Med. 2007 Oct; 20(4):573-80. PMID: 17786290.
      View in: PubMed
    39. Pashov A, Monzavi-Karbassi B, Chow M, Cannon M, Kieber-Emmons T. Immune surveillance as a rationale for immunotherapy? Hum Vaccin. 2007 Sep-Oct; 3(5):224-8. PMID: 17660717.
      View in: PubMed
    40. Monzavi-Karbassi B, Stanley JS, Hennings L, Jousheghany F, Artaud C, Shaaf S, Kieber-Emmons T. Chondroitin sulfate glycosaminoglycans as major P-selectin ligands on metastatic breast cancer cell lines. Int J Cancer. 2007 Mar 15; 120(6):1179-91. PMID: 17154173.
      View in: PubMed
    41. Hakkak R, MacLeod S, Shaaf S, Holley AW, Simpson P, Fuchs G, Jo CH, Kieber-Emmons T, Korourian S. Obesity increases the incidence of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in an ovariectomized Zucker rat model. Int J Oncol. 2007 Mar; 30(3):557-63. PMID: 17273756.
      View in: PubMed
    42. Monzavi-Karbassi B, Hennings LJ, Artaud C, Liu T, Jousheghany F, Pashov A, Murali R, Hutchins LF, Kieber-Emmons T. Preclinical studies of carbohydrate mimetic peptide vaccines for breast cancer and melanoma. Vaccine. 2007 Apr 20; 25(16):3022-31. PMID: 17303294.
      View in: PubMed
    43. Pashov A, Monzavi-Karbassi B, Raghava G, Kieber-Emmons T. Peptide mimotopes as prototypic templates of broad-spectrum surrogates of carbohydrate antigens for cancer vaccination. Crit Rev Immunol. 2007; 27(3):247-70. PMID: 18197820.
      View in: PubMed
    44. Pashov A, Perry M, Dyar M, Chow M, Kieber-Emmons T. Defining carbohydrate antigens as HIV vaccine candidates. Curr Pharm Des. 2007; 13(2):185-201. PMID: 17269927.
      View in: PubMed
    45. Pashov AD, Plaxco J, Kaveri SV, Monzavi-Karbassi B, Harn D, Kieber-Emmons T. Multiple antigenic mimotopes of HIV carbohydrate antigens: relating structure and antigenicity. J Biol Chem. 2006 Oct 06; 281(40):29675-83. PMID: 16899462.
      View in: PubMed
    46. Monzavi-Karbassi B, Pashov A, Jousheghany F, Artaud C, Kieber-Emmons T. Evaluating strategies to enhance the anti-tumor immune response to a carbohydrate mimetic peptide vaccine. Int J Mol Med. 2006 Jun; 17(6):1045-52. PMID: 16685414.
      View in: PubMed
    47. Carcel-Trullols J, Stanley JS, Saha R, Shaaf S, Bendre MS, Monzavi-Karbassi B, Suva LJ, Kieber-Emmons T. Characterization of the glycosylation profile of the human breast cancer cell line, MDA-231, and a bone colonizing variant. Int J Oncol. 2006 May; 28(5):1173-83. PMID: 16596233.
      View in: PubMed
    48. Monzavi-Karbassi B, Whitehead TL, Jousheghany F, Artaud C, Hennings L, Shaaf S, Slaughter A, Korourian S, Kelly T, Blaszczyk-Thurin M, Kieber-Emmons T. Deficiency in surface expression of E-selectin ligand promotes lung colonization in a mouse model of breast cancer. Int J Cancer. 2005 Nov 10; 117(3):398-408. PMID: 15906360.
      View in: PubMed
    49. Whitehead TL, Monzavi-Karbassi B, Jousheghany F, Artaud C, Elbein A, Kieber-Emmons T. 1H-NMR metabolic markers of malignancy correlate with spontaneous metastases in a murine mammary tumor model. Int J Oncol. 2005 Jul; 27(1):257-63. PMID: 15942667.
      View in: PubMed
    50. Pashov A, Canziani G, Monzavi-Karbassi B, Kaveri SV, Macleod S, Saha R, Perry M, Vancott TC, Kieber-Emmons T. Antigenic properties of peptide mimotopes of HIV-1-associated carbohydrate antigens. J Biol Chem. 2005 Aug 12; 280(32):28959-65. PMID: 15955803.
      View in: PubMed
    51. Hakkak R, Holley AW, Macleod SL, Simpson PM, Fuchs GJ, Jo CH, Kieber-Emmons T, Korourian S. Obesity promotes 7,12-dimethylbenz(a)anthracene-induced mammary tumor development in female zucker rats. Breast Cancer Res. 2005; 7(5):R627-33. PMID: 16168107; PMCID: PMC1242129.
    52. Monzavi-Karbassi B, Artaud C, Jousheghany F, Hennings L, Carcel-Trullols J, Shaaf S, Korourian S, Kieber-Emmons T. Reduction of spontaneous metastases through induction of carbohydrate cross-reactive apoptotic antibodies. J Immunol. 2005 Jun 01; 174(11):7057-65. PMID: 15905549.
      View in: PubMed
    53. Pashov A, MacLeod S, Saha R, Perry M, VanCott TC, Kieber-Emmons T. Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12. Glycobiology. 2005 Oct; 15(10):994-1001. PMID: 15917430.
      View in: PubMed
    54. Pashov A, Canziani G, Macleod S, Plaxco J, Monzavi-Karbassi B, Kieber-Emmons T. Targeting carbohydrate antigens in HIV vaccine development. Vaccine. 2005 Mar 18; 23(17-18):2168-75. PMID: 15755589.
      View in: PubMed
    55. Wen YJ, Mancino A, Pashov A, Whitehead T, Stanley J, Kieber-Emmons T. Antigen binding of human IgG Fabs mediate ERK-associated proliferation of human breast cancer cells. DNA Cell Biol. 2005 Feb; 24(2):73-84. PMID: 15699628.
      View in: PubMed
    56. Luo W, Hsu JC, Kieber-Emmons T, Wang X, Ferrone S. Human tumor associated antigen mimicry by xenoantigens, anti-idiotypic antibodies and peptide mimics: implications for immunotherapy of malignant diseases. Cancer Chemother Biol Response Modif. 2005; 22:769-87. PMID: 16110640.
      View in: PubMed
    57. Pashov A, Perry M, Dyar M, Chow M, Kieber-Emmons T. Carbohydrate mimotopes in the rational design of cancer vaccines. Curr Top Med Chem. 2005; 5(12):1171-85. PMID: 16248790.
      View in: PubMed
    58. Whitehead TL, Kieber-emmons T. Applications of in vitro NMR Spectroscopy and 1H-NMR metabonomics to breast cancer characterizaton and detection. Prog NMR Spectroscopy. 2005; 47:165-174.
    59. Whitehead TL, Monzavi-Karbassi B, Kieber-emmons T. 1H-NMR metabonomics analysis of sera differentiates between mammary tumor bearing mice and healthy controls. Metabolomics. 2005; 1(3):269-278.
    60. Langford JK, Yang Y, Kieber-Emmons T, Sanderson RD. Identification of an invasion regulatory domain within the core protein of syndecan-1. J Biol Chem. 2005 Feb 04; 280(5):3467-73. PMID: 15563454.
      View in: PubMed
    61. Monzavi-Karbassi B, Luo P, Jousheghany F, Torres-QuiƱones M, Cunto-Amesty G, Artaud C, Kieber-Emmons T. A mimic of tumor rejection antigen-associated carbohydrates mediates an antitumor cellular response. Cancer Res. 2004 Mar 15; 64(6):2162-6. PMID: 15026358.
      View in: PubMed
    62. Agadjanyan MG, Chattergoon MA, Holterman MJ, Monzavi-Karbassi B, Kim JJ, Dentchev T, Wilson D, Ayyavoo V, Montaner LJ, Kieber-Emmons T, Sekaly RP, Weiner DB. Costimulatory molecule immune enhancement in a plasmid vaccine model is regulated in part through the Ig constant-like domain of CD80/86. J Immunol. 2003 Oct 15; 171(8):4311-9. PMID: 14530356.
      View in: PubMed
    63. Prinz DM, Smithson SL, Kieber-Emmons T, Westerink MA. Induction of a protective capsular polysaccharide antibody response to a multiepitope DNA vaccine encoding a peptide mimic of meningococcal serogroup C capsular polysaccharide. Immunology. 2003 Oct; 110(2):242-9. PMID: 14511238; PMCID: PMC1783044.
    64. Cunto-Amesty G, Monzavi-Karbassi B, Luo P, Jousheghany F, Kieber-Emmons T. Strategies in cancer vaccines development. Int J Parasitol. 2003 May; 33(5-6):597-613. PMID: 12782058.
      View in: PubMed
    65. Villard S, Lacroix-Desmazes S, Kieber-Emmons T, Piquer D, Grailly S, Benhida A, Kaveri SV, Saint-Remy JM, Granier C. Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti-FVIII inhibitor. Blood. 2003 Aug 01; 102(3):949-52. PMID: 12676786.
      View in: PubMed
    66. Cribbs DH, Ghochikyan A, Vasilevko V, Tran M, Petrushina I, Sadzikava N, Babikyan D, Kesslak P, Kieber-Emmons T, Cotman CW, Agadjanyan MG. Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid. Int Immunol. 2003 Apr; 15(4):505-14. PMID: 12663680; PMCID: PMC1483061.
    67. Monzavi-Karbassi B, Shamloo S, Kieber-Emmons M, Jousheghany F, Luo P, Lin KY, Cunto-Amesty G, Weiner DB, Kieber-Emmons T. Priming characteristics of peptide mimotopes of carbohydrate antigens. Vaccine. 2003 Jan 30; 21(7-8):753-60. PMID: 12531355.
      View in: PubMed
    68. O I, Otvos L, Kieber-Emmons T, Blaszczyk-Thurin M. Role of SA-Le(a) and E-selectin in metastasis assessed with peptide antagonist. Peptides. 2002 May; 23(5):999-1010. PMID: 12084533.
      View in: PubMed
    69. Monzavi-Karbassi B, Cunto-Amesty G, Luo P, Kieber-Emmons T. Peptide mimotopes as surrogate antigens of carbohydrates in vaccine discovery. Trends Biotechnol. 2002 May; 20(5):207-14. PMID: 11943376.
      View in: PubMed
    70. Thurin M, Kieber-Emmons T. SA-Lea and tumor metastasis: the old prediction and recent findings. Hybrid Hybridomics. 2002 Apr; 21(2):111-6. PMID: 12031100.
      View in: PubMed
    71. Monzavi-Karbassi B, Cunto-Amesty G, Luo P, Kieber-Emmons T. Use of surrogate antigens as vaccines against cancer. Hybrid Hybridomics. 2002 Apr; 21(2):103-9. PMID: 12031099.
      View in: PubMed
    72. Monfardini C, Canziani G, Plugariu C, Kieber-Emmons T, Godillot AP, Kwah J, Bajgier J, Chaiken I, Williams WV. Structure-based design of mimetics for granulocyte-macrophage colony stimulating factor (GM-CSF). Curr Pharm Des. 2002; 8(24):2185-99. PMID: 12369862.
      View in: PubMed
    73. Monzavi-Karbassi B, Cunto-Amesty G, Luo P, Kieber-Emmons T. Carbohydrate Antigens as Targets for Immune therapy. Hybridoma. 2002; 21(2):103-9.
    74. Monzavi-Karbassi B, Cunto-Amesty G, Luo P, Kieber-Emmons T. Peptide mimotopes of carbohydrate antigens in vaccine discovery. Trends in Biotech. 2002; 20:207-14.
    75. Cunto-Amesty G, Kieber-Emmons T. Molecular Mimicry, Microbes and Autoimmunity. Exploiting Molecular Mimicry in Targeting Carbohydrate Antigens. 2000.
    76. Kohler H, Kaveri S, Kazatchkine M, Kieber-emmons T. Natural Selection Theory Revisited. Immunologist. 2000; 8:91-93.
    77. Kieber-Emmons T. Human Retroviral Infection: Immunological and Molecular Therapies. Carbohydrate interactions and HIV-1. 2000.
    78. O I, Otvos L, Blaszczyk-Thurin M, Kieber-Emmons T. Annals of the New York Academy of Sciences. Peptides mimicking sialyl-Lewis A isolated from a random peptide library and peptide array. 1999.
    79. Qui J-P, Zhou H, Aceto JF, Kieber-Emmons T. Non- Radioactive dTaq cycle sequencing for filamentous phage DNA. Biotechniques. 1997; 23:125-127.
    80. Madaio MP, Yanase K, Foster MH, Smith RM, Fabbi M, Puccetti A, Jarrett L, Kieber-Emmons T. Annals of the New York Academy of Sciences. Nuclear Localization of Autoantibodies: Novel Insights into Protein translocation and Cellular Function. 1997.
    81. Luo P, Agadjanyan M, Hutchins W, Westerink MAJ, Steplewski Z, Kieber-Emmons T. Vaccines: New Advances in Technologies and Applications. Peptide mimicry of carbohydrate epitopes. 1996.
    82. Prammer K, Wiener M, Kieber-Emmons T. Critical Reviews in Chemistry. Chemical and Structural Approaches to Rational Drug Design. Biocomputational approaches to rational protein based drug design. 1995.
    83. Aceto J, Cines DB, Prammer K, Kieber-emmons T. Conformational properties of the C-terminal GPI anchor domain of Urokinase receptor. Transgene. 1994; 1:203-217.
    84. Kieber-Emmons T. Biologically Active Peptides: Design, Syntheis, and Utilization. Rational approaches for peptide design. 1992.
    85. Ugen KE, Goedert JJ, Boyer J, Refaeli Y, Frank I, Willwams VW, Willoughby A, Landesman S, Rubinstein A, Kieber-emmons T, Weiner DB. Vertical transmissin of HIV infection: Correlation with reactivity of maternal sera to HIV-1 gp120 and gp41 peptides. J Clin Invest. 1992; 89:1923-1930.
    86. Tomiyama Y, Brojer E, Ruggeri Z, Shattil KA, Smiltneck J, Gorski J, Kunicki TJ, Kieber-Emmons T. A murine immunoglobulin heavy chain D region gene segment mimics Arg-Gly-Asp (RGD) containing ligands. J. Biol. Chem. 1992; 267:18085-18092.
    87. VonFeldt TJ, Ugen KE, Williams WV, Kieber-Emmons T. Biologically Active Peptides: Design, Syntheis, and Utilization. Bioactive peptide design based on antibody structure. 1992.
    88. Weiner DB, Kieber-Emmons T. 1992 AIDS Research Reviews. Structural perspective of the CD4 antigen. 1992.
    89. Shattil SJ, Weisel JW, Kieber-emmons T. Use of monoclonal antibodies to study the interaction between an integrin adhesion receptor, GPIIa-IIIb, and its physiological ligand, fibrinogen. Immunomethods. 1992; 1:53-63.
    90. Williams VW, Greene MI, Kieber-Emmons T. Monoclonal Antibodies: Application in Clincial Oncology. Anti- receptor antibody structure and peptide design. 1991.
    91. Ugen KE, Goodert JJ, Boyer J, Refaeli Y, Frank I, Williams WV, Willoughby A, Landesman S, Rubinstein A, Berzofsky J, Weiner DB, Kieber-Emmons T. Vaccines '92: Modern Approaches to New Vaccines Including Prevention of AIDS. Vertical t ransmission of HIV infection: Maternal humoral immune response to gp120 and gp41 peptides. 1991.
    92. Ugen KE, Merva M, Whalley A, Morrow WJW, Williams WV, Nara PL, Weiner DB, Kieber-Emmons T. Vaccines '91: Modern Approaches to New Vaccines Including Prevention of AIDS. Engineered peptides that mimic HIV-1 neutralizing envelope structures. 1991.
    93. Ugen KE, Perussia B, Kamun M, Merva MJ, Williams WV, Nara P, Weiner DB, Kieber-Emmons T. Vaccines '91: Modern Approaches to New Vaccines Including Prevention of AIDS. Inhibition of HIV-1 cellular infection by immunologic reagents. 1991.
    94. Williams WV, Weiner DB, Greene ME, Kieber-Emmons T. Studies in the Science of Complexity, Santa Fe Institute Series. Use of Antibodies as molecular mimics to probe intermolecular interaction landscapes. Molecular evolution of rugged landscapes: Proteins, RNA and the Immune System. 1991.
    95. Whalley A, Williams WM, Ryskamp T, Morrow WJW, Krowka J, Williams WV, Schmid I, Girogi JV, Merva MJ, Weiner DB, Kieber-Emmons T. Vaccines 90. Biological characteristics of an HIV-1 envelope-derived synthetic peptide. 1990.
    96. Williams WV, Weiner DB, Greene MI, Kieber-Emmons T. Arthritis Rheum. Molecular analysis of an autoantibody-receptor interaction. 1989.
    97. Koeler H, Kaveri S, Morrow WJW, Mueller S, Raychaudhuri S, Kieber-Emmons T. Meth. Enzymol. Overview of idiotypic networks and the nature of molecular mimicry. 1989.
    98. Koehler H, Kieber-Emmons T. Antibodies. New concepts in antibody structure. 1987.
    99. McNamara-Ward M, Ward RE, Koehler H, Kieber-Emmons T. Monographs in Allergy. Structural considerations in idiotype vaccine design. 1987.
    100. Koehler H, Cheng HL, Sood AK, McNamara-Ward M, Huang JH, Ward RE, Kieber-Emmons T. Idiotypes (Proc. Oklahoma Conf. on Idiotype Vaccines). On the mechanism of internal image vaccines. 1987.
    101. Getzof E, Koehler H, Kieber-Emmons T. Int. Rev. Immunol. Perspectives on idiotypes and antigenicity. 1987.
    102. Kieber-emmons T. Intermolecular interaction theory/ Computational structural biology. PhD Dissertation. 1985.
    103. Rein R, Shibata M, Garduno R, Kieber-Emmons T. Structure and Dynamics: Nucleic Acids and Proteins. Structure of mispairs leading to substitution mutations. 1983.
    104. Kieber-emmons T, Rein R. Comparison of theoretical and thermodynamic values of interconstituent interactions in DNA. Int J Quantum Chem. 1983; 23:1283-1293.
    105. Parthasarathy R, Rajewswaran M, Rein R, Kieber-Emmons T. Conformation in Biology: The Festschrift Celebrating the Sixtieth Birthday of G.N. Ramachandram, F.R.S. (R. Srinivasan and R.H. Sarma, eds.). Reciprocal conformational relationships of 2', 5' and 3', 5' polynucleotides: Single-stranded helices of 2', 5' polynucleotides. 1983.
    106. Rein R, Shibata M, Kieber-Emmons T. Frontiers of Chemistry: Plenary and Keynote Lectures Presented at 28th IUPAC Congress. Computer-aided studies of biomolecular structure and function. 1982.
    107. Rein T, Kieber-emmons T. Evolution and amino acid composition requirements of catalytic mechanisms. Studies in Organic Chem. 1982; 10:253-266.
    108. Shibata M, Kieber-emmons T, Dutta S, Rein R. A comparative analysis of the stability of the chymotrypsin charge triad. Int J Quantum Chem. QBS. 1981; 8:409-417.
    109. Rein R, Kieber-Emmons T. Origin of Life. Evolving nucleotide binding surfaces. 1981.
    110. Rein R, Kieber-emmons T. Theory of ionic effects on intermolecular interactions on polyions: Application to ethidium binding to DNA. Int J Quantum Chem. QBS. 1979; 6:481-489.
    Kieber-Emmons's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _